Glomerulonefritis por cambios mínimos post vacuna COVID-19 AstraZeneca

We report a case of a 28-year-old woman with minimal change disease secondary nephrotic syndrome 48 hours after the administration of the AstraZeneca SARS-CoV2 vaccine. The patient had suffered idiopathic nephrotic syndrome in childhood treated empirically with corticosteroids and cyclosporine, in c...

Full description

Saved in:

Bibliographic Details
Published in:	Revista de nefrología, diálisis y transplante Vol. 42; no. 1; pp. 65 - 68
Main Authors:	Pérez De Pedro, Fernando, Ernesto Caliva, Belén Faría, Rubio, Débora, Lotti, Alejandro
Format:	Journal Article
Language:	Portuguese Spanish
Published:	01-01-2022
Subjects:	coronavirus CoV COVID minimal change nephrotic syndrome SARS severe acute respiratory syndrome síndrome nefrótico de cambios mínimos síndrome respiratorio agudo severo vaccination vacunación
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	We report a case of a 28-year-old woman with minimal change disease secondary nephrotic syndrome 48 hours after the administration of the AstraZeneca SARS-CoV2 vaccine. The patient had suffered idiopathic nephrotic syndrome in childhood treated empirically with corticosteroids and cyclosporine, in complete remission from the age of 9. Some reports suggest that glomerular disease might appear infrequently associated to some vaccines. Reportamos un caso de una mujer de 28 años, con síndrome nefrótico debido a glomerulonefritis por cambios mínimos 48 horas después de la administración de la vacuna contra SARS-CoV2 de AstraZeneca. La paciente tuvo síndrome nefrótico idiopático en la infancia tratado empíricamente con corticoides y ciclosporina, en remisión completa desde los 9 años. Algunos reportes sugieren que determinadas enfermedades glomerulares podrían asociarse infrecuentemente a las vacunas.
ISSN:	2346-8548 0326-3428